aggression | CARLAT PUBLISHING

CARLAT WEBINAR

Aggression in Psychiatric Practice

May 24, 2023

0.50 CME Credits. Learn to mitigate aggression in psychiatric practice in this webinar. You will gain expertise in understanding, treating, and preventing challenging behaviors in children and adults.

The Evidence Base for Polypharmacy in ADHD

March 24, 2022

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Often our patients with ADHD do not seem to respond adequately to one medication. We try different medications and we try combining them, but does it work? This study looked at the outcomes for stimulants alone and in combination with central alpha agonists, divalproex, and risperidone. Does polypharmacy work? Read it and see!

Principles of Verbal De-Escalation

January 7, 2022

Janet Richmond, MSW.

Victoria Hendrick, MD. Editor-in-Chief of the Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Janet Richmond, MSW. Clinician at VA Boston Healthcare System and McLean Hospital, MA. Associate Clinical Professor of Psychiatry, Tufts University School of Medicine.

Dr. Hendrick and Ms. Richmond have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Simple strategies can be surprisingly effective in verbally de-escalating agitated patients.

Unpacking Aggression Associated with ADHD

October 18, 2021

John C. Blader, PhD

John C. Blader, PhD

Child and adolescent psychologist at the University of Texas Health Science Center, San Antonio, TX. Dr. Blader has disclosed that he has received funding from Supernus Pharmaceuticals for one research grant unrelated to this topic and these medications. Dr. Feder has reviewed this article and found no evidence of bias in this educational activity.

We often see children and teens who have ADHD with aggressive behavior. The press to treat them often results in polypharmacy with all the attendant risks and complications. This interview with Dr. Joseph Blader discusses research findings that can help us to provide more effective simplified and safer treatment for many of the patients.